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Abstract
Irritable bowel syndrome (IBS) is a chronic disorder that affects the
gastrointestinal system (GI) and is associated with abdominal pain and
changes in bowel movements. The standard first-line dietary interventions for
IBS are healthy eating and lifestyle changes. Once these diets are associated
with failure, more intense therapies are necessary. New approaches for
management of symptoms of IBS-D/IBS-C and quality of life has emerged
such as a low fermentable oligo-, di-, monosaccharides, and polyols
(FODMAP) diet because of its elimination process. This study found several
studies through a literature review that adults (≥ 18 years old) benefitted from
this novel therapy. More research is needed until a low FODMAP diet
intervention can be confirmed as effective or superior to other dietary
guidelines or restrictions.
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Irritable Bowel Syndrome (IBS)
Overview
➢ Altered GI motility, visceral hypersensitivity, and/or altered brain-gut axis
➢ Affects ~10% of the adult population globally
➢ Certain foods can be a trigger to GI symptoms 
Symptoms
➢ Abdominal pain, changes in bowel movements – diarrhea and/or 
constipation, bloating, flatus, fatigue and difficulty sleeping
➢ Associated with anxiety, depression, and decreased quality of life
Treatment
➢ 1st line dietary interventions for IBS are healthy eating and lifestyle 
changes
➢ Currently, a low FODMAP intervention diet is a novel approach to treat IBS 
symptoms.
➢ Therefore, this review analyzes the use of a low fermentable oligo-, di-, 
monosaccharides, and polyols (FODMAP) diet (I) for management of 
symptoms of IBS-D/ IBS-C and quality of life (O) in adults ((≥ 18 years 
old) with Irritable Bowel Syndrome (P) comparable to other dietary 
guidelines or restrictions (C).
Introduction
Methods
Literature Search 
➢ Performed in October 2018 using
✓Clinical Key
✓PubMed 
➢ Seven articles consisting of randomized control trials (RCT) were selected 
based on their relevance to the research question, intervention technique, 
sample population, and outcome measures. These articles were later 
compared based on their study design, results, and statistical relevance. 
4/7 studies report that a low FODMAP diet has equal or greater efficacy 
than 1st line of healthy eating and lifestyle changes in the treatment of IBS 
&
3/7 studies report that a GFD diet has equal or greater efficacy than 1st
line of healthy eating and lifestyle changes in the treatment of IBS 
Strengths
➢ All studies are RCT → allows for unbiased distribution of confounding 
variables
➢ Statistically significant results → 7/7 studies used p-values < 0.05
➢ Blinding Methods → minimized bias and maximized the validity of the 
results
➢ No study reported negative side-effects of the dietary interventions
Limitations
➢ Small sample sizes
➢ Recruitment methods
➢ Short study duration with only one study having an 18-month follow-up
Future Research
➢ Comparing a low FODMAP and GFD dietary intervention
➢ Recruit larger, more diverse population samples
➢ Long-term effects of low FODMAP and GFD diet
➢ Cost effectiveness of adhering to the diet
Discussion 
Study Demographics Control Diet Interventional Diet Diet Length Outcome Measure
1 Female: 31
Male: 10
GFD with HLA-DQ2/8 negative GFD with HLA-DQ2/8 positive 6 wks
IBS-SSS, HADS, FIS, SF-36 QOL
2 Female: 56
Male: 11
Traditional IBS diet Low FODMAP
29 days
IBS-SSS, BSFS, HADS, VSI, Multidimensional Fatigue 
Inventory-20
3 Female: 65
Male: 27
mNICE Low FODMAP
4 wks
BSFS, IBS-QOL, HADS, Work Productivity and Activity 
Impairment, Seep and Fatigue 
4
Female: 27
Male: 11
Diet containing FODMAP 
content of a typical Australian 
diet
Low FODMAP 21-day diet, washout pd of at least 21 days, then 
cross over to 21-day to the alternate diet
Gastrointestinal symptoms were measured by VAS, KSC
5
Female: 15
Male: 5
Low FODMAP
High FODMAP
2 day IBS school, 9 wks of LFD, then after 3 wks
supplement of either high FODMAP (A) or low 
FODMAP (B) followed by a 3-wk washout, and then 
reverse sequence
IBS-SSS
6
Female: 53
Male: 19
GFD GCD 6 wks GFD, then 6 wks of either GFD or GCD
Bloating, abdominal pain, defecation satisfaction, nausea, 
fatigue, and overall symptoms, and scored with the VAS
7
Female: 43
Male: 2
GCD
GFD 4 wks
BSFS, HADS, HLA Genotyping, Measurement of Gastric 
Emptying, Small Bowel and Colonic Transit with Scintigraphy
Key: IBS-SSS: IBS-Symptom Severity Score, HADS: Hospital Anxiety and Depression Scale, SF-QOL:  Short-form 36 Quality of Life; GFD: Gluten-Free Diet, VAS: Visual analogue scale, KSC: King’s Stool Chart, BSFD: Bristol Stool 
Form Scale, FODMAP: Fermentable oligo-, di-, monosaccharides, and polyols 
Table 1. Comparison of Results 
The Effects of a Low FODMAP Diet Compared to 
Other Diet Guidelines in Patients Over 18 with IBS
The study results are positive, however more research is needed in order to 
make a definitive conclusion. For the patients suffering from IBS who have 
failed current first-line dietary recommendations and lifestyle modifications, a 
low FODMAP appears to be a practical and potentially effective option. 
Until more research is available, it remains unclear if symptom relief provided 
by a low FODMAP diet can be sustained for long-term IBS management after 
the elimination phase and reintroduction phase. There is not yet enough 
evidence to validate a change in the standard IBS treatment practice, however 
there are significantly enough positive results to promote future research.
In regards to future research, it should aim to compare a low FODMAP and 
GFD dietary intervention and their effectiveness in the management of 
symptoms and quality of life, as well as, the long term effectiveness of these 
interventions.
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